← FDA DRUG APPROVALS

FDA ANDA · ANDA071076

HALOPERIDOL

Sponsor: PUREPAC PHARM

APPLICATION
ANDA071076
TYPE
ANDA
ORIGINAL APPROVAL
1987-08-04
LATEST ACTION
1998-02-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HALOPERIDOLDiscontinued
HALOPERIDOL 20MG · TABLET · ORAL

Approval history

1998-02-20Labeling · Supplement 5AP
1991-05-09Labeling · Supplement 13AP
1989-04-19Labeling · Supplement 10AP
1988-11-16Labeling · Supplement 9AP
1987-08-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →